SCG
GILD icon

Strategic Capital Group’s Gilead Sciences GILD Stock Holding History

Strategic Capital Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$4.5M Buy
54,260
+25,502
+89% +$1.99M 1.4% 20
2014
Q1 		$2.04M Buy
28,758
+28,237
+5,420% +$2.21M 0.66% 63
2013
Q4 		$39K Sell
521
-120
-19% -$8.36K 0.03% 189
2013
Q3 		$40K Buy
641
+200
+45% +$12K 0.02% 209
2013
Q2 		$23K Buy
+441
New +$23K 0.01% 213

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Strategic Capital Group's GILD Position: Q2 2014 in Review

Strategic Capital Group increased its Gilead Sciences (GILD) stake by 89% in Q2 2014, buying an estimated $1.99M and bringing the position to 54,260 shares worth $4.5M. The position accounts for 1.4% of the portfolio, ranked #20.

Strategic Capital Group first reported a position in GILD in Q2 2013 and has held it in 5 quarters since. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Strategic Capital Group held 54,260 shares of Gilead Sciences worth $4.5M as of Q2 2014.
  • Strategic Capital Group bought 25,502 Gilead Sciences shares in Q2 2014, an estimated $1.99M.
  • Gilead Sciences made up 1.4% of Strategic Capital Group's portfolio in Q2 2014, its #20 holding.
  • Strategic Capital Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 5 quarters since.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Strategic Capital Group's 13F filing for Q2 2014, filed 14 Jul 2014.